The Vox Markets Podcast / Tim Watts, CEO of Shield Therapeutics provides an update on its plans to commercialise Accrufer® in the USA

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.